Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Alibaba Health Information Technology Cash Ratio?
Alibaba Health Information TechnologyALBHF +1.57%53 Cash Ratio is 2.00 as of Mar. 2026, which is 3% above its 10-year median of 1.95. GuruFocus rates ALBHF with a GF Score™ of 53/100 and a GF Value™ of $0.69 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 80.18% on this metric.
Alibaba Health Information Technology has a Cash Ratio of 2.00. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
Alibaba Health Information Technology (OTCPK:ALBHF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Alibaba Health Information Technology Cash Ratio Related Terms
Alibaba Health Information Technology Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Cash Ratio Chart
Alibaba Health Information Technology Cash Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (ALBHF) has a Cash Ratio of 2.00 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alibaba Health Information Technology and its competitors. This is near median its historical median of 1.95. Over the past decade, Alibaba Health Information Technology's Cash Ratio has ranged from 0.62 to 3.42. According to the industry distribution chart, Alibaba Health Information Technology ranks #132 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 19.8%.
Is Alibaba Health Information Technology's Cash Ratio too high?
Alibaba Health Information Technology's current Cash Ratio of 2.00 is near median its 10-year median of 1.95. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 3.42. The Healthcare Providers & Services industry median Cash Ratio is 0.58. Alibaba Health Information Technology's value of 2.00 is 244.8% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #132 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Cash Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #132 out of 666 companies for Cash Ratio. This places Alibaba Health Information Technology in the top 20% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.58. Alibaba Health Information Technology's value of 2.00 is 244.8% above this benchmark. Historically, Alibaba Health Information Technology's own Cash Ratio has ranged from 0.62 to 3.42 over the past decade. While the company's 10-year median is 1.95 vs. the industry median of 0.58, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Cash Ratio of 2.00 is 244.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Cash Ratio is 2.00, which is near median its own 10-year median of 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.69, compared to a current price of $0.44 — trading 36.2% below its estimated fair value. The current Cash Ratio is 2.00, which is near median its 10-year median of 1.95 and 244.8% above the Healthcare Providers & Services industry median of 0.58. Alibaba Health Information Technology's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Cash Ratio is 2.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.44 is trading 36.2% below its estimated GF Value™ of $0.69.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
Cash Ratio: 2.00 (near median its 10-year median of 1.95)
GF Value™: $0.69 vs. price of $0.44 (36.2% below fair value)
Industry Position: 244.8% above the Healthcare Providers & Services median (#132 of 666)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
53GF Score
Get the complete analysis for ALBHF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
